Optimum is proud to sponsor the 2020 European Mediscience Award for Best Communications. This is awarded to the company who will have demonstrated its ability to successfully communicate its investment message to its targets in the mediscience sector. This years’ finalists include Abcam PLC, Argenx SE, Calliditas Therapeutics and Ergomed PLC. With the spotlight on the […]
Read more on VelosBio in this latest blog post by Arix Managing Director and VelosBio Board Director Jonathan Tobin
As many countries continue to pass the peak of COVID-19, Masters Speciality Pharma’s Head of Licensing, Sid Masters believes now is a good time to reflect on the challenges, successes and response of the pharmaceutical industry during the pandemic. Sid writes: Over the past few months we have seen Covid-19 wreak havoc by crippling our […]
The Optimum Strategic Communications European VC Report confirmed that there is a substantial amount of money available for investment in European companies. We spoke to 24 of the most influential European VCs, investing approximately EUR 15.5 billion in aggregate in the Healthcare sector, who are actively seeking and reviewing new opportunities. However in the current […]
Since taking over as CEO of Calliditas Therapeutics in 2017, Renee Aguiar-Lucander has taken the biotech through an IPO in Stockholm and commenced a pivotal phase 3 trial plus major licensing deals and a secondary fund raise. She has established a US presence, made transformational regulatory milestones, and this month completed a successful upsized US […]
